20900 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids
Treatments for Gastrointestinal Disorders
#302ORAL FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS
#303PHAGE-PEPTIDE CONSTRUCTS FOR STIMULATION OF AN ANTI-CANCER IMMUNE RESPONSE AGAINST CD47
#304PHOSPHORYLCHOLINE CONJUGATES AND USES THEREOF
#305Use of PAYCS in regulation of intestinal flora, metabolites, and brain neurotransmitters
#306PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#307COMPOSITION FOR PREVENTION, IMPROVEMENT OR TREATMENT OF ALLERGIC DISEASE OR ITCHING COMPRISING PENTAPEPTIDE AS ACTIVE INGREDIENT
#308NANOPARTICLES AND METHODS OF MANUFACTURE THEREOF
#309TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs)
#310Short Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa
#311METHODS FOR ATTENUATING RELEASE OF INFLAMMATORY MEDIATORS AND PEPTIDES USEFUL THEREIN
#312Method for treating gingivitis and gingival atrophy and repairing oral mucosa
#313MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME
#314MIXTURES AND FORMULATIONS
#315Saposin-A derived peptides and uses thereof
#316PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#317PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#318PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#319Peptide exhibiting wrinkle-improving activity and uses thereof
#320Peptide exhibiting wrinkle-improving activity and uses thereof
#321HISTATIN FOR CORNEAL WOUND HEALING AND OCULAR SURFACE DISEASE
#322MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF
#323NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#324PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#325COMPOSITION FOR OVERCOMING RESISTANCE TO EGFR-TARGETING AGENT
#326COSMETIC OR DERMATOLOGICAL PEPTIDE-BASED TREATMENT OF THE SKIN AND ITS INTEGUMENTS
#327PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VITILIGO
#328V1A Receptor Partial Agonist and Method of Use
#329B*44 restricted peptides for use in immunotherapy against cancers and related methods
#330Anti-EDB antibodies and antibody-drug conjugates
#331Compositions and Methods for Treating Granulomatosis with Polyangiitis
#332METHODS AND MEANS FOR MODIFYING HEMODYNAMICS IN INFECTIONS
#333PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#334PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#335PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#336PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#337PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#338PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#339PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#340PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#341PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#342PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#343EFFECTIVE TREATMENTS FOR VASCULAR ASSOCIATED MACULOPATHY, SEVERE MACULOPATHY, LATE-STAGE MACULOPATHY, AND ABERRANT CHORIOCAPILLARIS
#344PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#345COMPOSITIONS AND METHODS FOR TREATMENT
#346PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#347COMPOSITIONS AND METHODS FOR TREATING INFECTIONS AND NETOPATHY
#348Novel Pharmaceutical Composition for Treating Dry Eye Syndrome
#349A SYNERGISTIC FORMULATION FOR MANAGEMENT OF RESPIRATORY PATHOGENS INCLUDING CORONAVIRUSES
#350Methods and compositions for delivery of biotin to mitochondria
#351S100A8-INHIBITING PEPTIDE AND DISEASE THERAPEUTIC AGENT CONTAINING SAME
#352METHOD OF TREATING CORONAVIRUS INFECTIONS
#353Compositions and methods of targeting cancer stem cells
#354NOVEL PEPTIDE INHIBITORS OF BETA-LACTAMASE AGAINST ANTIBIOTIC RESISTANCE
#355LARAZOTIDE DERIVATIVES COMPRISING D-AMINO ACIDS
#356COMPOSITION COMPRISING PENTAPEPTIDE AS ACTIVE INGREDIENT
#357METHODS FOR REDUCING CD36 EXPRESSION
#358RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R
#359Methods and compositions for delivery of biotin to mitochondria
#360NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#361IMMUNE CHECKPOINT INHIBITOR COMBINATIONS
#362ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#363LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#364PEPTIDE THERAPEUTICS FOR ACUTE AND CHRONIC AIRWAY AND ALVEOLAR DISEASES
#365CEACAM based antibacterial agents
#366PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
#367NEW METHOD TO TREAT CUTANEOUS T-CELL LYMPHOMAS AND TFH DERIVED LYMPHOMAS
#368POLYPEPTIDE FOR PROMOTING BONE REGENERATION OR BONE FORMATION AND ITS USE
#369ALLERGEN PROTECTION AGAINST URUSHIOLS
#370CHANNEL MODULATORS
#371PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME
#372INHIBITION OF SARS-COV-2 INFECTION THROUGH SYNDECANS
#373PEPTOID-CONTAINING PERSONAL LUBRICANT
#374COMPOSITIONS AND METHOD OF MODULATING GROWTH FACTOR FUNCTION
#375TREATMENT OF PANX1 ASSOCIATES DISEASES
#376NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#377METHODS FOR REDUCING OXIDATIVE DAMAGE
#378METHOD OF MANUFACTURING PEPTIDE NANOPARTICLES
#379TREATMENT OF INFLAMMATORY DISEASES WITH PEPTIDES AND PHARMACEUTICAL COMPOSITIONS
#380ACE inhibitory peptide composition derived from ginkgo protein and preparation method and application thereof
#381COMPOSITIONS FOR PREVENTING OR TREATING VIRAL AND OTHER MICROBIAL INFECTIONS
#382HETEROCLITIC CANCER VACCINES
#383PEPTIDES AND USES THEREOF
#384CAR Peptide for Improved Coronavirus Survival
#385MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#386MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#387COMPOSITION CONTAINING PEPTIDE OR PEPTIDE COMPOUND AS ACTIVE INGREDIENT, AND MEDICAL USE THEREFOR
#388PEPTIDOMIMETIC MACROCYCLES
#389METHOD OF INJECTING OCTREOTIDE ACETATE INTO THE BODY
#390PEPTIDES AND PHARMACEUTICAL, NUTRACEUTICAL OR VETERINARY COMPOSITIONS FOR HAIR LOSS PREVENTION AND/OR TREATMENT
#391GLYCOTARGETING THERAPEUTICS
#392NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#393METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
#394Treatment of Parasitic Infections of Fish Surfaces
#395MICELLES AND VESICLES FOR THE DELIVERY OF GLYCOPEPTIDES
#396Peptides and methods for treating disease
#397NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS
#398INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
#399SLEEP-INDUCING BEVERAGE COMPOSITION, ITS METHOD OF PRODUCTION AND THE METHOD OF USE
#400COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES
#401Compounds with Antimicrobial Properties
#402NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#403ENHANCEMENT OF CD47 BLOCKADE THERAPY BY PROTEASOME INHIBITORS
#404NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#405NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#406ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS
#407Peptide Inhibitors Targeting Methyltransfer Mechanism of SARS-CoV-2
#408Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof
#409TARGETING PAR1 AND PAR2 TO REGULATE LIPID AND CHOLESTEROL ABUNDANCE
#410Modulation Of Endoplasmic Reticulum Aminopeptidase 2 (ERAP2)-Mediated Immune Response
#411Compositions targeting the interaction domain between p27KIP1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity
#412PEPTIDE COMPOUNDS AND METHODS OF TREATING DISEASES USING SAME
#413METHODS OF INCREASING ENDOGENOUS LUTEINIZING HORMONE
#414Methods and compositions for delivery of biotin to mitochondria
#415PEPTIDE CONSTRUCTS AND COMPOSITIONS
#416METHODS AND COMPOSITIONS COMPRISING A CT20 PEPTIDE
#417TEIPP PEPTIDE VARIANT AND USES THEREOF
#418Coronavirus Therapeutics and Treatment Methods
#419B*44 restricted peptides for use in immunotherapy against cancers and related methods
#420B*44 restricted peptides for use in immunotherapy against cancers and related methods
#421B*44 restricted peptides for use in immunotherapy against cancers and related methods
#422B*44 restricted peptides for use in immunotherapy against cancers and related methods
#423DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#424Glycan-Interacting Compounds and Methods of Use
#425ANTIVIRAL PEPTOID COMPOSITIONS
#426THERAPEUTIC APPROACH FOR TREATING INFLAMMATORY BOWEL DISEASE
#427UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION
#428Method of treating diseases
#429Pharmaceutical compositions and related methods of delivery
#430Pharmaceutical compositions and related methods of delivery
#431Compositions and method for optimized peptide vaccines using residue optimization
#432PEPTIDE, COMPOSITION, AND METHOD FOR TREATING, PREVENTING, OR AMELIORATING MOOD DISORDER
#433INTEGRIN RECEPTOR ALPHA V BETA 3 AND ITS LIGAND INVOLVED IN CHRONIC ITCH
#434PEPTIDE THERAPEUTICS FOR ACUTE AND CHRONIC AIRWAY AND ALVEOLAR DISEASES
#435INHIBITING ZD17-JNK INTERACTION AS A THERAPY FOR ACUTE MYOCARDIAL INFARCTION
#436METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY
#437Peptides and combination thereof for use in the immunotherapy against cancers
#438Topical compositions
#439PEPTIDE PHARMACEUTICALS
#440STABILIZED PEPTIDE COMPOSITION
#441COMPOSITIONS AND METHODS FOR TREATMENT
#442QUORUM-SENSING INHIBITORS AND/OR POSTBIOTIC METABOLITES AND RELATED METHODS
#443COMPOSITION FOR PROMOTING HAIR GROWTH, AND ALLEVIATING AND TREATING HAIR LOSS INCLUDING SUBSTANCE P
#444Methods and compositions for delivery of biotin to mitochondria
#445ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#446DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION
#447SUSTAINED-RELEASE MICROPARTICLES FOR SUSTAINED RELEASE OF DRUG
#448Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use
#449INTERLEUKIN 15 FUSION PROTEIN FOR TUMOR TARGETING THERAPY
#450PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS
#451COMPOSITIONS AND METHODS OF TREATING CANCER WITH GLYCOMIMETIC PEPTIDES
#452ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS
#453LARAZOTIDE FORMULATIONS
#454MATERIALS FOR DELIVERY OF TETHERABLE PROTEINS IN BONE IMPLANTS
#455METHODS FOR TREATING METASTATIC STAGE PROSTATE CANCER
#456Use of interference peptide in preparation of anti-SARS-CoV-2 medicament
#457Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#458INHIBITION OF TUMOR NECROSIS FACTOR, PRO-INFLAMMATORY CYTOKINES AND OTHER IMFLAMMATORY RESPONSE MEDIATORS
#459USE OF TREM-1 INHIBITORS FOR TREATMENT, ELIMINATION AND ERADICATION OF HIV-1 INFECTION
#460PEPTIDES AND METHODS OF USE THEREOF IN TREATING UVEITIS
#461SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS
#462CELL PENETRATING PEPTIDES FOR INTRACELLULAR DELIVERY OF MOLECULES
#463Methods and compositions for increasing the dose of a chemotherapeutic agent
#464Immunostimulatory method
#465PEPTIDES HAVING INHIBITORY ACTIVITY ON NEURONAL EXOCYTOSIS
#466SYNTHETIC ANTIMICROBIAL PEPTIDES
#467TREATMENT APPROACH BY TARGETED DELIVERY OF BIOACTIVE MOLECULES
#468Bioactive peptide molecules discovered by a combination of bioinformatics technique and chemical synthesis
#469ANTIBODIES THAT BIND TO LRP6 PROTEINS AND METHODS OF USE
#470Immunotherapeutic composition and uses thereof
#471APPLICATION OF POLYPEPTIDE OR DERIVATIVE THEREOF
#472PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
#473COMPOUNDS AND METHODS FOR INHIBITING PROTOZOAN PARASITES
#474PHARMACEUTICAL COMPOSITION, USE AND METHOD FOR APPLYING GANODERMA MICROSPORUM IMMUNOMODULATORY PROTEIN AND KEYHOLE LIMPET HEMOCYANIN IN CARCINOMA TREATMENT
#475ORGANIC COMPOUNDS
#476CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#477COMPOSITION AND METHOD FOR PROMOTING WOUND HEALING
#478Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers
#479Hemostatic composition and hemostatic method using hemostatic composition
#480METHOD OF ADMINISTERING A DUAL THERAPEUTIC AND COSMETIC AGENT
#481ACE INHIBITORY PEPTIDE COMPOSITION DERIVED FROM GINKGO PROTEIN AND PREPARATION METHOD AND APPLICATION THEREOF
#482Methods and compositions for identifying neoantigens for use in treating cancer
#483Mixtures and formulations
#484Methods and compositions for identifying neoantigens for use in treating and preventing cancer
#485Antimicrobial compositions and methods of use thereof
#486TREATMENT OF IMPLANTS WITH ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES
#487COMPOSITIONS AND METHODS FOR TREATING ACUTE RADIATION SYNDROME
#488A FORMULATION OF A CONJUGATE OF A TUBULYSIN ANALOG TO A CELL-BINDING MOLECULE
#489INHIBITORS OF IL-15 AND THEIR USE IN TREATING AUTOIMMUNE/INFLAMMATORY DISORDERS
#490Method of treating diseases
#491Treatments for Gastrointestinal Disorders
#492Cyclic peptide analogs and conjugates thereof
#493SYNTHETIC COMPOUND
#494Method of treating prostate cancer with GnRH antagonist
#495Composition and Concentrate for Use in Preparation of Dialysis Solution, Corresponding Dialysis Solution and Combinations Comprising Container
#496Storage stable sincalide formulations
#497B-CATENIN/B-CELL LYMPHOMA 9 PROTEIN-PROTEIN INTERACTION INHIBITING PEPTIDOMIMETICS
#498METHODS FOR TREATING METASTATIC STAGE PROSTATE CANCER
#499METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST
#500Peptide for treating sepsis derived from Rv2626c protein of
#501Peptides and combination of peptides for use in immunotherapy against various tumors
#502THERAPEUTIC PEPTIDES
#503Compositions, delivery systems, and methods useful in tumor therapy
#504Short synthetic peptides and their uses for treating retinal degenerative diseases and/or tissue injuries
#505POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING
#506Low-burst polymers and methods to produce polymer
#507COMPOSITION FOR CONTROLLED RELEASE OF THERAPEUTIC AGENTS
#508Tissue occluding agent comprising an ieikieikieiki peptide
#509Compositions comprising peptides comprising variant kinesin light chain 1 and cell-penetrating peptides
#510METHOD FOR INHIBITING PLATELET DERIVED GROWTH FACTOR SIGNALING WITH C3aR OR C5aR ANTIBODIES
#511HYPOXIA-INDUCING CRYOGELS
#512Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
#513THERAPY FOR SUBARACHNOID HEMORRHAGE AND ISCHEMIA
#514ANGIO-3 FOR TREATMENT OF RETINAL ANGIOGENIC DISEASES
#515METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES
#516POLYMERIC NANOPARTICLES AND A PROCESS OF PREPARATION THEREOF
#517PEPTIDE NANOPARTICLES AND USES THEREFOR
#518Formulations containing a somatostatin receptor agonist
#519Lipoprotein targeting protease inhibitors and uses
#520Peptide composition from early harvested rice and methods for slimming or promoting growth of probiotics using the same
#521COMPOSITIONS AND METHODS OF USE FOR TREATMENT OR IMPROVEMENT OF THE CONDITION AND APPEARANCE OF SKIN
#522Anti-B7-H4 antibodies and immunoconjugates
#523Synthetic somatostatin receptor ligands
#524ANTIFUNGAL AGENTS AND USES THEREOF
#525Pharmaceutical compositions
#526PEPTIDES AND USES THEREOF
#527COMPOSITIONS AND METHODS FOR PROTECTING TYPE 2 ALVEOLAR EPITHELIAL CELLS (AEC2)
#528Cyclic prosaposin peptides and uses thereof
#529Peptides Having Immunomodulatory Properties
#530TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A S1P MODULATOR
#531PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES
#532PHARMACEUTICAL COMPOSITIONS TO ENHANCE PHAGOCYTOSIS WITHOUT INFLAMMATION
#533Compositions for preventing or treating viral and other microbial infections
#534Method of injecting octreotide acetate into the body
#535CD38 Antibody Drug Conjugate
#536Methods comprising desmopressin
#537Compositions and methods of treating melanoma
#538CD154 PEPTIDES AND METHODS OF INHIBITING CD40 INTERACTIONS WITH CD154
#539ADHESIVE FOR OSSEOINTEGRATED PERCUTANEOUS DEVICES
#540BIOORTHOGONAL COMPOSITIONS
#541NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS
#542PEPTIDE TAGS FOR LIGAND INDUCED DEGRADATION OF FUSION PROTEINS
#543Inhibition of pulmonary fibrosis with nutlin-3A and peptides
#544COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
#545Method and compositions comprising a CT20 peptide
#546Antimicrobial compounds from the genus
#547COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB
#548Tyrosine Inhibitors with Immunosuppressive Activity in Human Neonatal Keratinocyte Progenitors
#549PHARMACEUTICAL COMPOSITION, COMPRISING INHIBITORY PEPTIDE AGAINST FAS SIGNALING, FOR PREVENTION OR TREATMENT OF OBESITY, FATTY LIVER, OR STEATOHEPATITIS
#550Methods of treating female infertility
#551SPECIFIC PEPTIDE CLATHRIN INHIBITORS
#552METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
#553Methods and compositions for delivery of biotin to mitochondria
#554Methods for Modulating Macrophage Activity
#555METHODS FOR TREATING DISEASE AND REDUCING DRUG-INDUCED LIVER INJURY IN PATIENT POPULATIONS
#556Biomaterials comprising hyaluronic acid binding peptides and extracellular matrix binding peptides for hyaluronic acid retention and tissue engineering applications
#557Preparation method of yeast powder rich in nicotinamide mononucleotide, yeast powder, and methods for improving skin condition, hair health, antiinflammation, cardiovascular health, antioxidation, antiaging and/or relieving body fatigue
#558Deep wrinkle vanishing compositions
#559NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#560Methods for treating symptoms of dry eye disease
#561ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD)
#562METHODS FOR MODULATING REGULATORY T CELLS AND INHIBITING TUMOR GROWTH
#563Alpha(v)beta(6) integrin-binding peptides and methods of use thereof
#564COMPOSITIONS AND METHODS FOR TREATING SJOGREN'S SYNDROME
#565Stable liquid formulation of AMG 416 (etelcalcetide)
#566Peptides and combination of peptides for use in immunotherapy against various tumors
#567Peptides and combination of peptides for use in immunotherapy against various tumors
#568Agonists of Human Kisspeptin Receptor for Modulating Sexual Desire
#569COMBINATION THERAPY OF ARMS AND NATURAL KILLER CELLS
#570Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 infection
#571Peptides and combination of peptides for use in immunotherapy against various tumors
#572METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST
#573PEPTIDES FOR TREATING NON-EXUDATIVE MACULAR DEGENERATION AND OTHER DISORDERS OF THE EYE
#574Alpha-v beta-6 integrin ligands and uses thereof
#575INHIBITING INFLAMMATION
#576Pharmaceutical compositions and methods targeting Wnt pathway proteins
#577Pharmaceutical composition for preventing or treating cancer, containing oligopeptide as active ingredient
#578Peptides and combination of peptides for use in immunotherapy against various tumors
#579Peptides and combination of peptides for use in immunotherapy against various tumors
#580GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES
#581HYDROGEL COMPOSITION AND ASSOCIATED METHOD OF USE
#582Peptides and combination of peptides for use in immunotherapy against various tumors
#583PEPTIDE INHIBITORS OF TIGHT JUNCTION PERMEABILITY
#584METHODS OF TREATING COVID-19 PATHOGENESIS
#585Peptides and combination of peptides for use in immunotherapy against various tumors
#586PEPTIDOMIMETIC MACROCYCLES
#587SYNTHETIC PEPTIDES INDUCING IMMUNOGENIC CELL DEATH
#588Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#589Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody
#590Peptides and combination of peptides for use in immunotherapy against various tumors
#591IMMUNE CHECKPOINT INHIBITOR COMBINATIONS
#592Peptides Having Immunomodulatory Properties
#593PHARMACEUTICAL FORMULATIONS OF PEPTIDE INHIBITORS
#594Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
#595Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances
#596Peptides and combination of peptides for use in immunotherapy against various tumors
#597Peptides and combination of peptides for use in immunotherapy against various tumors
#598Peptides and combination of peptides for use in immunotherapy against various tumors
#599Peptides and combination of peptides for use in immunotherapy against various tumors
#600Peptides and combination of peptides for use in immunotherapy against various tumors